haematology

News in brief: DOAC and heavy menstrual bleeding; 3 risk factors for CIPN; better BBV screening required in NHL

Low dose DOAC safer option to reduce heavy menstrual bleeding Menstrual bleeding patterns are not statistically different in women taking high or low-dose rivaroxaban or aspirin. However, given evidence for similar efficacy in the secondary prevention of VTE, 10 mg rivaroxaban might be safer with regard to heavy menstrual bleeding than 20mg. A sub-study of ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic